Hepatic Metabolic Clearance of Midazolam, a Cytochrome P450 3A Substrate, in the Presence of Ketoconazole in Rats

Author： Higashikawa F. Murakami T. Makino M. Takano M.

ISSN： 1460-8081

Source： Pharmacy and Pharmacology Communications, Vol.5, Iss.8, 1999-08, pp. : 529-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling: Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil

By Perdaems Nathalie

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 239-258

Adis International

Access to resources Recommend Favorite

Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children: How Accurate Are Available Scaling Methods?

By Björkman Sven

Clinical Pharmacokinetics, Vol. 45, Iss. 1, 2006-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates

By Monette M. Cotreau Lisa L. von Moltke David J. Greenblatt

Clinical Pharmacokinetics, Vol. 44, Iss. 1, 2005-01 ,pp. : 33-60

Adis International

Access to resources Recommend Favorite

Effects of Enzyme Sources on Midazolam 1-Hydroxylation Activity Catalyzed by Recombinant Cytochrome P450 3A4 in Combination with NADPH-Cytochrome P450 Reductase

Drug Metabolism Letters, Vol. 2, Iss. 3, 2008-08 ,pp. : 190-192

Bentham Science Publishers

Access to resources Recommend Favorite

Potential inhibitory effect of herbal medicines on rat hepatic cytochrome P450 2D gene expression and metabolic activity

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 11, 2014-11 ,pp. : 799-803

Govi-Verlag

Access to resources Recommend Favorite